Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 5/2007

01-10-2007 | ORIGINAL ARTICLE

Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population

Authors: Ryusaburo Furuya, Yasuhiko Onoye, Akiko Kanayama, Takeshi Saika, Takako Iyoda, Mitsuhiro Tatewaki, Kaoru Matsuzaki, Intetsu Kobayashi, Masatoshi Tanaka

Published in: Journal of Infection and Chemotherapy | Issue 5/2007

Login to get access
Metadata
Title
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population
Authors
Ryusaburo Furuya
Yasuhiko Onoye
Akiko Kanayama
Takeshi Saika
Takako Iyoda
Mitsuhiro Tatewaki
Kaoru Matsuzaki
Intetsu Kobayashi
Masatoshi Tanaka
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 5/2007
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-007-0541-8

Other articles of this Issue 5/2007

Journal of Infection and Chemotherapy 5/2007 Go to the issue

CASE REPORT

Pneumopericardium due to invasive pulmonary aspergillosis

CASE REPORT

Rapidly progressive fatal pneumococcal sepsis in adults: a report of two cases

ORIGINAL ARTICLE

Primary resistance in Helicobacter pylori isolated in children from Iran

ORIGINAL ARTICLE

A change in the effectiveness of amantadine for the treatment of influenza over the 2003–2004, 2004–2005, and 2005–2006 influenza seasons in Japan

ORIGINAL ARTICLE

Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and β-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia

ORIGINAL ARTICLE

Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits